NCT07043361View on ClinicalTrials.gov

Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels

CompletedOBSERVATIONAL

Enrollment

5,300

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

December 21, 2024

Study Completion Date

April 30, 2025

Conditions

Metabolic Disease

Interventions

DRUG

semaglutide

testing the effect of baseline vitamin D on metabolic effects of semaglutide

Trial Locations (1)

333300

Leumit Health ccare system, Hadera

All Listed Sponsors

lead

Hillel Yaffe Medical Center

OTHER_GOV

NCT07043361 - Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels | Biotech Hunter | Biotech Hunter